GTG 2.22% 9.2¢ genetic technologies limited

News: GTG Genetic Technologies Signs Multi-Year US Distribution Agreement For COVID Risk Test

  1. 189,634 Posts.
    lightbulb Created with Sketch. 2782

    March 4 (Reuters) - Genetic Technologies Ltd (GTG) :

    • GENETIC TECHNOLOGIES SIGNS MULTI-YEAR US DISTRIBUTION AGREEMENT FOR COVID RISK TEST
    • GENETIC TECHNOLOGIES LTD - CO SIGNS CO-EXCLUSIVE PRODUCTION AND DISTRIBUTION RIGHTS AND LICENSE AGREEMENT WITH INFINITY BIOLOGIX LLC
    • GENETIC TECHNOLOGIES LTD - IBX IS REQUIRED TO MAKE MINIMUM PAYMENTS TO CO TOTALING US$2.9 MILLION OVER TERM TO MAINTAIN EXCLUSIVITY
    • GENETIC TECHNOLOGIES LTD - UNDERLYING ROYALTY STRUCTURE IS ON A PER UNIT BASIS OF US$10
    • GENETIC TECHNOLOGIES LTD - IBX WILL DEFINE AND DECIDE SALES AND END-TO-CONSUMER PRICING STRUCTURE FOR COVID-19 RISK TEST
    • GENETIC TECHNOLOGIES LTD - GTG TEAM IS IN FINAL STAGES TO SUBMIT COVID-19 RISK TEST FOR CLEARANCE FROM CLINICAL LABORATORY IMPROVEMENT AMENDMENTS
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
9.2¢
Change
0.002(2.22%)
Mkt cap ! $12.16M
Open High Low Value Volume
8.7¢ 9.2¢ 8.7¢ $2.809K 31.31K

Buyers (Bids)

No. Vol. Price($)
1 50000 8.8¢
 

Sellers (Offers)

Price($) Vol. No.
9.2¢ 484 1
View Market Depth
Last trade - 15.53pm 21/06/2024 (20 minute delay) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.